SecSonar.com

Integra LifeSciences Holdings Corporation (IART)

Integra LifeSciences Holdings Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Integra LifeSciences Holdings Corporation (IART) is a Medical - Devices company based in US with a market capitalization of $1.3B. Revenue grew 1.5% year-over-year and free cash flow was negative at -$31.1M. This page tracks IART's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 4.4K employees · IPO Aug 16, 1995

Valuation

Valuation & price

$14.10 · as of May 17, 2026 · -24.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.23

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$18.76$13.83$8.90Jul 25Dec 25Jun 26Jul 7, 25$12.75Jul 9, 25$13.05Jul 11, 25$12.59Jul 15, 25$11.74Jul 17, 25$11.98Jul 21, 25$11.37Jul 23, 25$12.80Jul 25, 25$13.11Jul 29, 25$12.86Jul 31, 25$13.14Aug 4, 25$12.56Aug 6, 25$12.37Aug 8, 25$12.96Aug 12, 25$13.77Aug 14, 25$13.62Aug 18, 25$14.05Aug 20, 25$14.26Aug 22, 25$14.86Aug 26, 25$14.76Aug 28, 25$14.84Sep 3, 25$15.13Sep 5, 25$15.99Sep 9, 25$15.43Sep 11, 25$15.47Sep 15, 25$15.07Sep 17, 25$14.80Sep 19, 25$14.13Sep 23, 25$13.97Sep 25, 25$13.18Sep 29, 25$13.63Oct 1, 25$14.73Oct 3, 25$14.80Oct 7, 25$14.43Oct 9, 25$14.16Oct 13, 25$13.62Oct 15, 25$14.23Oct 17, 25$15.08Oct 21, 25$15.88Oct 23, 25$15.88Oct 27, 25$15.93Oct 30, 25$11.81Nov 3, 25$11.49Nov 5, 25$11.40Nov 7, 25$12.04Nov 11, 25$12.33Nov 13, 25$12.04Nov 17, 25$11.73Nov 19, 25$11.15Nov 21, 25$12.04Nov 25, 25$13.25Nov 28, 25$13.12Dec 2, 25$13.16Dec 4, 25$13.57Dec 8, 25$13.02Dec 10, 25$13.66Dec 12, 25$13.42Dec 16, 25$13.00Dec 18, 25$13.05Dec 22, 25$12.57Dec 24, 25$12.66Dec 29, 25$12.61Jan 2, 26$12.01Jan 6, 26$13.13Jan 8, 26$13.86Jan 12, 26$13.15Jan 14, 26$12.53Jan 16, 26$12.41Jan 21, 26$12.19Jan 23, 26$11.90Jan 27, 26$11.13Jan 29, 26$11.09Feb 2, 26$11.16Feb 4, 26$11.08Feb 6, 26$11.26Feb 10, 26$10.98Feb 12, 26$10.81Feb 17, 26$11.44Feb 19, 26$12.05Feb 23, 26$11.76Feb 25, 26$11.59Mar 2, 26$10.43Mar 4, 26$10.39Mar 6, 26$9.73Mar 10, 26$9.55Mar 12, 26$9.17Mar 16, 26$9.01Mar 18, 26$8.90Mar 20, 26$8.94Mar 24, 26$9.54Mar 26, 26$9.38Mar 30, 26$9.12Apr 1, 26$9.57Apr 6, 26$9.31Apr 8, 26$9.62Apr 10, 26$9.90Apr 14, 26$11.06Apr 16, 26$10.84Apr 20, 26$11.16Apr 22, 26$10.75Apr 24, 26$10.57Apr 28, 26$10.74May 1, 26$10.95May 5, 26$13.22May 7, 26$13.56May 11, 26$13.97May 13, 26$14.90May 15, 26$14.10May 19, 26$14.38May 21, 26$15.12May 26, 26$15.19May 28, 26$16.46Jun 1, 26$15.67Jun 3, 26$16.10Jun 5, 26$16.99Jun 9, 26$17.90Jun 11, 26$17.51Jun 15, 26$17.46Jun 17, 26$17.20Jun 22, 26$17.60Jun 26, 26$18.76
$8.9052-week range$18.76
Loading valuation history…

Fundamentals

Key fundamentals

$1.3B

Market cap

1.5%

Revenue growth (YoY)

51.7%

Gross margin

-$31.1M

Free cash flow (USD)

$1.8B

Net debt

-0.3%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$992.1MFY 2017$1.2BFY 2018$1.5BFY 2019$1.5BFY 2020$1.4BFY 2021$1.5BFY 2022$1.6BFY 2023$1.5BFY 2024$1.6BFY 2025$1.6B
$992.1M$1.6B

Free cash flow by year

2016 → 2025

FY 2016$69.1MFY 2017$71.0MFY 2018$121.9MFY 2019$96.9MFY 2020$139.9MFY 2021$264.3MFY 2022$217.4MFY 2023$73.1MFY 2024$25.0MFY 2025$-31.1M
$69.1M-$31.1M

Gross margin by year

2021 → 2025

FY 202161.2%FY 202262.3%FY 202357.4%FY 202454.8%FY 202551.7%
61.2%51.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 5, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsMay 8, 2026Filing
  • 8-K eventEarnings ReleaseMay 5, 2026Filing
  • 8-K eventCEO AppointmentMay 5, 2026Filing
  • Quarterly report10-Q FiledMay 5, 2026Filing
  • 8-K eventDebt RefinancingApr 15, 2026Filing

Questions

Frequently asked questions

What is Integra LifeSciences Holdings Corporation's market cap?

Integra LifeSciences Holdings Corporation (IART) has a market capitalization of $1.3B.

What is IART's P/E ratio?

A meaningful P/E ratio is not available for IART — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is IART's price-to-book (P/B) ratio?

IART trades at 1.23 times book value per share.

Are insiders buying IART stock?

SEC Form 4 filings show no open-market insider buys at Integra LifeSciences Holdings Corporation in the last 90 days (0 sells).

Same arena

Related companies in Medical - Devices

ENOV

Enovis Corporation

$1.3B

INSP

Inspire Medical Systems, Inc.

$1.2B

ATEC

Alphatec Holdings, Inc.

$1.2B

IRMD

IRadimed Corporation

$1.2B

TNDM

Tandem Diabetes Care, Inc.

$1.2B

AHCO

AdaptHealth Corp.

$1.4B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.